Toshiya Nomura
- Nephrology top 10%
- Parathyroid Disorders and Treatments 3
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 19
- Protein Kinase Regulation and GTPase Signaling 4
-
- Alzheimer's disease research and treatments 6
-
- Dermatological and Skeletal Disorders 4
-
- Peptidase Inhibition and Analysis 3
-
- Eosinophilic Disorders and Syndromes 3
-
- Cellular transport and secretion 3
- Co-authors
- Mitsuharu UedaYohei MisumiYukio AndoTaro YamashitaTeruaki MasudaHong TangYong LinMasayoshi Tasaki
- Partner nations
- JapanUnited StatesRussia
In The Last Decade
Toshiya Nomura
32 papers receiving 348 citations
Peers
Comparison fields: 5 of 66
- Nephrology 45
- Hepatology 28
- Molecular Biology 212
- Neurology 38
- Physiology 65
Countries citing papers authored by Toshiya Nomura
This map shows the geographic impact of Toshiya Nomura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiya Nomura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiya Nomura more than expected).
Fields of papers citing papers by Toshiya Nomura
This network shows the impact of papers produced by Toshiya Nomura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiya Nomura. The network helps show where Toshiya Nomura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiya Nomura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 6 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 6 | |
| 12 | 2019 | 6 | |
| 13 | 2019 | 8 | |
| 14 | 2017 | 40 | |
| 15 | 2017 | 22 | |
| 16 | Infection in myelodysplastic syndromes before evolution into acute non-lymphoblastic leukemia. | 1994 | 11 |
| 17 | 1993 | 10 | |
| 18 | 1992 | 4 | |
| 19 | Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent. | 1986 | 2 |
| 20 | 1985 | 12 |
About Toshiya Nomura
Toshiya Nomura is a scholar working on Nephrology, Molecular Biology and Neurology, having authored 35 papers that have together received 355 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Alzheimer's disease research and treatments (6 papers), Dermatological and Skeletal Disorders (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Parathyroid Disorders and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Nephrology (45 citations), Hepatology (28 citations) and Molecular Biology (212 citations). Toshiya Nomura has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Mitsuharu Ueda, Yohei Misumi, Yukio Ando, Taro Yamashita, Teruaki Masuda, Hong Tang, Yong Lin, Masayoshi Tasaki, Seishi Murakami and Toshinari Yamashita. Their work appears in journals such as Journal of Biological Chemistry, Neurology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.